Galderma Settles Pimple Drug Patent Suit With Par
The companies asked the court to stay the case as they finalize their settlement agreement and prepare a motion to dismiss the suit.
“The parties expect to jointly file a motion to dismiss this action within the next 30 days,” the motion said. “Accordingly, the parties jointly move to stay...
To view the full article, register now.